Aurobindo Pharma Q2 PAT seen up 5.8% to Rs 617.3 cr: Centrum

Net Sales are expected to increase by 5.9 percent Q-o-Q (up 18.4 percent Y-o-Y) to Rs 3945.3 crore, according to Centrum.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money IThe Winning Leap SME Special
Moneycontrol

Home » News » Earnings » Brokerage Results Estimates

Oct 19, 2016, 02.59 PM | Source: Moneycontrol.com

Aurobindo Pharma Q2 PAT seen up 5.8% to Rs 617.3 cr: Centrum

Net Sales are expected to increase by 5.9 percent Q-o-Q (up 18.4 percent Y-o-Y) to Rs 3945.3 crore, according to Centrum.

Like this story, share it with millions of investors on M3

Aurobindo Pharma Q2 PAT seen up 5.8% to Rs 617.3 cr: Centrum

Net Sales are expected to increase by 5.9 percent Q-o-Q (up 18.4 percent Y-o-Y) to Rs 3945.3 crore, according to Centrum.

Post Your Comments

Share Cancel

Centrum Broking (more)

, Centrum Broking |

Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Aurobindo Pharma  to report net profit at Rs 617.3 crore, up 5.8 percent quarter-on-quarter.

Net Sales are expected to increase by 5.9 percent Q-o-Q (up 18.4 percent Y-o-Y) to Rs 3945.3 crore, according to Centrum.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 7.1 percent Q-o-Q (up 22.8 percent Y-o-Y) to Rs 952.3 crore.

Centrum's report on Aurobindo Pharma

We expect 37% YoY increase in net profit to Rs 6.17bn from Rs4.52bn, largely driven by strong revenue growth and 80bps YoY margin improvement.

We expect the ARV and controlled substance businesses to report good performance. We expect the growth momentum to continue in H2FY17 as the company has plans to launch 19 new products in the US market.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Buy, Hold, Sell ? Hear it first on M3
Aurobindo Pharma Q2 PAT seen up 5.8% to Rs 617.3 cr: Centrum

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login